Project Grant R21AI185067

Award Date 6/4/24
Completion Date 4/30/26
Dollars Obligated $871K
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Iowa City, IA 52242, USA
Similar Awards
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), is providing $162,512 to the Regents of the University of Minnesota to investigate the factors that support the expansion and function of long-lived effector CD8 T cells within the memory compartment. The key objectives are to determine what pro-inflammatory cytokines and other factors promote the formation and...
This three-year, $3.456 million project grant from the National Institute of Mental Health (NIMH) Mental Health Research Grants program (CFDA 93.242) will fund research into the role of microglia in neurodevelopmental disorders. The grantee, Cold Spring Harbor Laboratory, will merge two-photon imaging of microglia and synapses in the brains of live mice with single-cell genomics and CRISPR screens. This will help define microglia's role in experience-dependent synaptic refinement, a process...
This $475,369 federal Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to better understand how microglia (the brain's resident macrophages) are programmed by the brain environment following transplantation. The primary awardee, The Trustees of the University of Pennsylvania, will use single-cell RNA and ATAC sequencing to...
This Project Grant award, valued at $3,931,590.00, was provided by the National Institute on Aging (CFDA 93.866 - Aging Research) to investigate the mechanisms underlying the neuroprotective effects of nasally administered anti-CD3 in mouse models of Alzheimer's disease (AD). The key objectives are to: 1) Investigate how nasal administration of anti-CD3 monoclonal antibody modulates microglia and astrocytes in the 3xTG mouse model of AD, including evaluating pharmacokinetics, behavioral...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) for $426,829 supports the development of a microphysiological system that models the brain-meninges-lymph node axis in both healthy and Alzheimer's disease conditions. The grant, awarded to Virginia Polytechnic Institute & State University, will integrate tissue-engineered models of the human brain, lymph node, and meninges into a microfluidic device to study the interactions between these...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $2,283,334.00 to the Morehouse School of Medicine (MSM) to develop and validate a progressive mouse model for Traumatic Brain Injury-related Alzheimer's Disease and Related Dementias (TBI-ADRD). The project aims to systematically screen mouse strains and TBI injury types to identify the optimal model for recapitulating key neuropathological, neurobiochemical, and neurocognitive features of human...
This Project Grant award, valued at $107,948.00, was provided by the National Institute on Aging under the Aging Research Federal Grant Program (CFDA 93.866) to the Regents of the University of Minnesota. The award supports research aimed at understanding the role of regulatory T cells in the progression of Alzheimer's disease (AD). The project has two specific aims: 1) to characterize the types and spatial localization of regulatory T cells in the aging brains of wild-type and AD model mice,...
This $427,625 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to elucidate the mechanisms by which microgliopathy, a genetic neurological disorder, causes early-onset dementia. The research will investigate how the loss of the DAP12 protein in microglia, the immune cells of the brain, leads to heightened signaling of the RUNX and STAT3 pathways. This dysregulation is hypothesized to disrupt normal microglial functions and induce brain pathology and...
The National Institute on Aging (NIA) awarded a $640,895 Project Grant (CFDA 93.866 - Aging Research) to the University of Wisconsin - Madison to develop a novel mouse model for Alzheimer's disease (AD) research. The goal is to characterize a microglia-specific mouse mutant that exhibits strong tauopathy and atrophy specifically in the entorhinal cortex, which is an early indicator of cognitive decline in AD patients. The project aims to determine the spatial and temporal progression of...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), supports research to increase understanding of the neurobiological mechanisms underlying cognitive deficits associated with neurodevelopmental disorders. The $289,119 award to the University of Texas Health Science Center at San Antonio aims to identify a critical developmental period for the regulation of cognitive speed in a mouse model for...

BRAIN T CELL INTERACTIONS IN MICROBIAL EXPERIENCED MICE - T CELLS IN THE BRAIN HAVE LONG BEEN ASSOCIATED WITH PATHOGENIC OUTCOMES, WITH THE HEALTHY BRAIN CONSIDERED AN IMMUNE PRIVILEGED ORGAN. THIS CONCEPT HAS RECENTLY BEEN OVERTURNED WITH THE DESCRIPTION OF MENINGEAL LYMPHATICS, ROLES FOR IMMUNE CELLS IN NORMAL BRAIN HOMEOSTASIS, AND DETECTION OF T CELLS IN THE BRAINS OF HEALTHY SUBJECTS AND IN AGING SUBJECTS WITH NEUROLOGICAL DISEASE. WHY THESE T CELLS ARE IN THE HEALTHY BRAIN AND WHAT ROLE THEY PLAY IN THIS CRITICAL TISSUE REMAIN MAJOR KNOWLEDGE GAPS. DUE TO THEIR ABNORMALLY HYGENIC HOUSING CONDITIONS, YOUNG ADULT SPF MICE DISPLAY PERIPHERAL IMMUNE SYSTEMS THAT RESEMBLE INFANT CORD BLOOD. IN CONTRAST, SIGNATURES OF REPEATED MICROBIAL EXPOSURE ARE ALREADY EVIDENT IN CHILDREN AND YOUNG ADULT HUMANS AND THESE SIGNATURES INTENSIFY WITH AGE. SPECIFIC TO THIS PROPOSAL, YOUNG ADULT SPF MICE, WHICH ARE THE SUBJECTS IN MANY IF NOT MOST ANIMAL MODELS OF NEUROSCIENCE RESEARCH, HAVE LOW NUMBERS OF T CELLS IN THEIR BRAINS AT HOMEOSTASIS. SEVERAL MODELS HAVE BEEN IMPLEMENTED TO "NORMALIZE" THE PERIPHERAL IMMUNE SYSTEM OF INBRED SPF MICE TO BETTER MIMIC HUMANS. ONE INFORMATIVE APPROACH, TO GENERATE SUCH "DIRTY MICE" LEVERAGES THE CO-HOUSING (COH) OF SPF MICE WITH PATHOGEN-INFESTED "PET STORE" MICE TO PERMIT NATURAL TRANSFER OF MOUSE PATHOGENS. ALTERNATIVELY, REPEATED EXPOSURE OF SPF MICE TO KNOWN LABORATORY PATHOGENS (SPECIFIC PATHOGEN EXPOSED, SPEXP MICE) HAS EMERGED AS A TRACTABLE APPROACH THAT CAN BE USED AT LOWER BIOCONTAINMENT THAN THE COH APPROACH. STUDIES WITH THESE MODELS HAVE LARGELY FOCUSED ON UNDERSTANDING HOW "NORMALIZATION" OF THE IMMUNE SYSTEM INFLUENCES PERIPHERAL IMMUNE RESPONSES TO INFECTION OR TUMORS WITHIN LYMPHOID ORGANS AND BARRIER TISSUES. THUS, THE IMPACT OF REPEATED MICROBIAL EXPOSURE ON THE GENERATION OF BRAIN-SURVEILLING T CELLS IS CURRENTLY UNKNOWN. OUR PRELIMINARY STUDIES REVEAL THAT NOT ONLY DOES REPEATED MICROBIAL EXPOSURE NORMALIZE THE PERIPHERAL IMMUNE SYSTEM, IT ALSO RESULTS IN SUBSTANTIAL AND SPECIFIC INCREASES IN MEMORY CD4 AND CD8 T CELL NUMBERS IN THE BRAIN. IN PARALLEL, OUR PRELIMINARY DATA SHOW HERE THAT BRAIN-RESIDING T CELLS INTERACT WITH OTHER IMMUNE CELLS IN THE CNS, INCLUDING CD11C+ DENDRITIC CELLS (DCS), THAT PERFORM ESSENTIAL FUNCTIONS DURING BRAIN HOMEOSTASIS AND IN RESPONSE TO BRAIN TRAUMA, INFECTIONS, TUMORS, AND NEURODEGENERATION. DUE TO THE HEAVY RELIANCE ON SPF MICE FOR STUDIES OF BRAIN FUNCTION, THE CONSEQUENCES HAVING "NORMALIZED" POPULATIONS OF BRAIN-RESIDING MEMORY T CELLS DURING HOMEOSTASIS OR NEUROLOGICAL DISEASE REMAIN UNKNOWN. OUR LONG-TERM GOAL IS TO EXPLOIT MODELS OF REPEATED MICROBIAL EXPOSURE TO "NORMALIZE" THE IMMUNE SYSTEM AND UNDERSTAND THE ROLES OF BRAIN-RESIDING MEMORY T CELLS IN SHAPING BRAIN FUNCTION AND NEUROIMMUNE RESPONSES. SPECIFIC AIM 1. DETERMINE HOW "NORMALIZED" NUMBERS OF BRAIN-RESIDING CD8 AND CD4 T CELLS IMPACT THE FUNCTIONAL STATUS AND CELLULAR INTERACTIONS OF BRAIN MICROGLIA AND CD11C+ DCS AT HOMEOSTASIS. 1.1. DETERMINE THE EPIGENETIC AND TRANSCRIPTOMIC LANDSCAPE OF MYELOID CELLS IN SPF AND SPEXP MICE. 1.2. VISUALIZE THE SPATIOTEMPORAL DYNAMICS OF DIRECT T CELL-MYELOID INTERACTIONS IN VIVO IN SPF AND SPEXP MICE.

Posted 6/4/24, 12:00 AM